# FDA Inspection 685683 - Redmed Inc - October 19, 2010

Source: https://www.keypedia.com/records/fda_inspections/redmed-inc/3e97b37e-520b-4b19-b7f2-c71f2c9bc6cf
Source feed: FDA_Inspections

> FDA Inspection 685683 for Redmed Inc on October 19, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 685683
- Company Name: Redmed Inc
- Inspection Date: 2010-10-19
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1258018 - 2024-12-12](https://www.keypedia.com/records/fda_inspections/redmed-inc/32c2fc89-14c9-4650-b824-cb8a03c96ba9)
- [FDA Inspection 1258018 - 2024-12-12](https://www.keypedia.com/records/fda_inspections/redmed-inc/a5ed1e17-f0f3-442d-a3ee-a2039cf000df)
- [FDA Inspection 1098290 - 2019-06-24](https://www.keypedia.com/records/fda_inspections/redmed-inc/799f45bd-4c27-46e0-9d6c-ac0a885bb934)
- [FDA Inspection 867835 - 2014-02-24](https://www.keypedia.com/records/fda_inspections/redmed-inc/3c28f689-9f0d-4f51-9373-d956e6424927)

Company: https://www.keypedia.com/companies/redmed-inc/ae44343f-7e85-4c02-850f-8c87234945ee

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d